Premier Anesthesia Forms Strategic Partnership with City of Hope Phoenix to Drive Cancer Care Expansion

ALPHARETTA, Ga.--(BUSINESS WIRE)--Premier Anesthesia, a leading, privately held anesthesia practice management firm, today announced a new partnership with City of Hope^® Phoenix Cancer Center, marking its expansion into the Arizona healthcare market and enhancing its commitment to comprehensive cancer care.

City of Hope Phoenix Cancer Center is a nationally accredited oncology institution committed to delivering patient-centered care and is renowned for its advanced therapies for blood cancer, including leukemia, myeloma and rare hematologic conditions. The center also manages one of the nation’s largest and most successful bone marrow transplant programs. Through this partnership, Premier Anesthesia will provide operational and clinical support, serving a key role in City of Hope’s planned expansion through 2026.

“Expanding access to high‑quality cancer services requires strong clinical partners aligned in mission and values,” said Dr. Alan H. Bryce, medical oncologist and chief clinical officer at City of Hope Phoenix Cancer Center. “This collaboration strengthens our ability to deliver compassionate, evidence‑based care and research to more patients in Arizona and to do it closer to home as we work together to improve outcomes for all Arizonans.”

“Our partnership represents an important step beyond geographic expansion by reinforcing shared values in mission, culture and patient care,” added Preston Smith, president of Premier Anesthesia. “City of Hope maintains a strong focus on the patient experience throughout all stages of care, a principle that is integral to Premier’s anesthesia services. We are honored to contribute to City of Hope’s vision and support its sustained growth in Arizona.”

Together, Premier Anesthesia and City of Hope are committed to providing compassionate, high-quality care. Their partnership is designed to help ensure anesthesia services enhance both clinical excellence and the overall patient experience as cancer care continues to evolve in Arizona.

About City of Hope

City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, Orange County, California, campus, a network of clinical care locations across Southern California and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope™.

For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

About Premier Anesthesia

Premier Anesthesia is one of the nation’s largest privately held anesthesia practice management companies. Solely focused on building and managing the best anesthesia teams in the industry, its leadership brings extensive experience and expertise in hospital-based physician staffing, recruiting and management, helping hospital and healthcare facilities across the country achieve superior clinical, business and patient outcomes. Premier Anesthesia is part of the Jackson Healthcare^® family of companies. Learn more at premieranesthesia.com.